S. 3797

Summary

S. 3797, the Prohibiting Tianeptine and Other Dangerous Products Act of 2026, was introduced in the Senate on Feb 5, 2026 by Sen. Richard Durbin (D) with 1 co-sponsor. It was referred to Health, Education, Labor, And Pensions, and last saw action on Feb 5, 2026: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S512).

Record

Text

S. 3797 has 1 co-sponsor.

119 S3797 IS: Prohibiting Tianeptine and Other Dangerous Products Act of 2026
 U.S. Senate
 2026-02-05
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 II  119th CONGRESS  2d Session  S. 3797  IN THE SENATE OF THE UNITED STATES   February 5, 2026   Mr. Durbin  (for himself and  Mr. Blumenthal ) introduced the following bill; which was read twice and referred to the  Committee on Health, Education, Labor, and Pensions    A BILL
To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.
1.
Short title
This Act may be cited as the   Prohibiting Tianeptine and Other Dangerous Products Act of 2026  .
2.
New prohibited acts relating to dietary supplements
(a)
In general
Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ) is amended by adding at the end the following:
(jjj)
The introduction or delivery for introduction into interstate commerce of any product marketed as a dietary supplement that does not meet the definition of a dietary supplement under section 201(ff).
(kkk)
The introduction or delivery for introduction into interstate commerce of a dietary supplement that has been prepared, packed, or held using the assistance of, or at the direction of, a person debarred under section 306.
 .
(b)
New import exclusion
Section 801(a) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 381(a) ) is amended in paragraph (3) of the third sentence, by striking  section 301(ll)  and inserting  paragraph (ll), (jjj), or (kkk) of section 301 .
(c)
New seizure authorities
Section 304 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 334 ) is amended—
(1)
in subsection (a)(1), in the first sentence, by striking  section section 301(ll), 404, or 505  and inserting  paragraph (ll), (jjj), or (kkk) of section 301, section 404, or section 505 ; and
(2)
in subsection (d)(1), in the first sentence, by inserting  , or product in violation of paragraph (jjj) or (kkk) of section 301,  after  condemned under this section .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

A bill to amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.

Sponsors

Sen. Richard Durbin (D) sponsors S. 3797, and 1 member has co-sponsored it from the day it was introduced.

Richard Durbin

Sen. · D–IL · Sponsor

Introduced Feb 5, 2026

Richard Blumenthal

Sen. · D–CT · Co-sponsor

Joined Feb 5, 2026 · Original

Show 2 of 2 rows

PreviousNext

Committees

S. 3797 went before 1 committee: Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions

Health, Education, Labor, and Pensions

Referred To · Feb 5, 2026 · 747 Bills

Actions

S. 3797 has taken 2 actions since Feb 5, 2026.

Votes

S. 3797 has not gone to a roll call.

Related bills

1 bill is related to S. 3797, as Identical bill.

HR 7407Prohibiting Tianeptine and Other Dangerous Products Act of 2026Feb 5, 2026 · Referred to the House Committee on Energy and Commerce. · Identical bill

Show 1 of 1 row

PreviousNext

Titles

S. 3797 goes by 3 titles, 1 of them short titles.

• Prohibiting Tianeptine and Other Dangerous Products Act of 2026 — Display Title
• Prohibiting Tianeptine and Other Dangerous Products Act of 2026 — Short Title(s) as Introduced
• A bill to amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements. — Official Title as Introduced

Lobbying

2 clients hired 2 firms and 5 registered lobbyists who named S. 3797 in 3 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Consumer Issues/Safety/Products, Defense, Food Industry (safety, labeling, etc.), Tariff (miscellaneous tariff bills), Indian/Native American Affairs.

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files S. 3797 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; S. 3797’s is Health.

Source: congress.gov · legiscan.com